| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total current assets | 4,751,048 | 8,241,721 | ||
| Property and equipment, net of depreciation | 19,908 | 24,689 | ||
| Deferred offering costs | 455,726 | - | ||
| Total assets | 5,226,682 | 8,266,410 | ||
| Total stockholders' equity (deficit) | 1,425,979 | 6,147,706 | ||
| Total liabilities and stockholders' equity (deficit) | 5,226,682 | 8,266,410 | ||
Transcode Therapeutics, Inc. (RNAZ)
Transcode Therapeutics, Inc. (RNAZ)